References
- Adeyemi E O, Neumann S, Chadwick V S, Hodgson H J F, Pepys M B. Circulating human leucocyte elastase in patients with inflammatory bowel disease. Gut 1985; 26: 1306–1311
- Fagan E A, Dyck R F, Maton P N, Hodgson H J F, Chadwick V S, Pepys M R. Serum levels of c-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982; 12: 351–360
- Best W R, Becktel J M, Singleton J W. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979; 77: 843–845
- Adeyemi E O, Campos L B, Loizou S, Walport M J, Hodgson H J F. Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus. Br J Rheum 1990; 6: 15–20
- Adeyemi E O, Hodgson H J F. Augmented release of human leucocyte lactoferrin (and elastase) during coagulation. J Clin Lab Immunol 1988; 27: 1–4
- Truelove S C, Witts L J. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2: 1041–1048
- Meyers S, Wolke A, Field S P, Feuer E J, Johnson J W, Janowitz H D. Faecal alpha-1-antitrypsin measurements: an indicator of Crohn's disease activity. Gastroenterology 1985; 89: 13–18
- Campieri M, Lanfranchi G A, Bazzocchi G, et al. Treatment of ulcerative colitis with high dose 5-amino salicylic acid enemas. Lancet 1981; 2: 270–272